NCT03665376

Brief Summary

The main goal of ERAS is to enhance the recovery of patients, and this has secondary effects, such reduced length of hospital stay, minimal postoperative complications and lessen readmission rates. ERAS protocols have been shown to be feasible and safe across the world. Although it has been shown to be effective in the developed settings and can potentially reduce the length of hospital stay, and the cost of healthcare in the perioperative period. The multimodal program of ERAS has been less implemented in the low and middle income African countries. Studies done outside Uganda (Egypt and South Africa) have demonstrated that ERAS program can be feasible and yields favorable outcomes in patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2017

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 11, 2018

Completed
Last Updated

September 11, 2018

Status Verified

September 1, 2018

Enrollment Period

2 months

First QC Date

September 5, 2018

Last Update Submit

September 9, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Length of hospital stay

    It is the duration of a single episode of hospitalization measured as time .

    From the day of surgical operation up to time 14 days

Secondary Outcomes (2)

  • Perioperative morbidity and mortality

    From the start of surgical intervention to 14 days after discharge from the hospital

  • Readmission rate

    Within 14 days from the day of discharge from the hospital

Study Arms (2)

ERAS arm

EXPERIMENTAL

Preoperative: Counseling and education about the ERAS program; Oral intake until 6 hours before the surgery; Carbohydrate drinks load; No mechanical bowel preparation; Antithrombotic prophylaxis (Tinzaparin 3500 IU) Intraoperative: Spinal anaesthesia (15 mg hyperbaric Bupivacaine + 200mcg intrathecal Morphine); Intravenous Ceftriaxone 2g, Metronidazole 500mg / Gentamycin 160mg, Ondansetron 8mg and Dexamethasone 8mg; Crystalloid fluid 10 to 20ml/Kg; Adrenaline 200mcg in each 500 ml of intravenous fluid; Avoidance of abdominal drains; Postoperative: Early oral intake; Nasogastric tube and urinary catheter removed immediately after the surgery; Early enteral nutrition; Chewing gum for 2 to 4 hours after surgery; Oral sips 8 hours postoperatively; Intravenous fluids discontinued at four hours after transfer to the ward.

Dietary Supplement: Carbohydrate drink loadCombination Product: Enhanced Recovery After Surgery (ERAS)

Control arm

NO INTERVENTION

Preoperative: No carbohydrate drink loads, no antithrombotic prophylaxis; Mechanical bowel preparation as needed; Spinal anaesthesia, fluid therapy and antibiotherapy done according to standard hospital practice. The urinary catheter and drains were removed at the discretion of the surgeon. Postoperative: Enteral feeding delayed by the auscultation of bowel sounds. The standard hospital practices involve keeping active the nasogastric tube, fasting patients postoperative, strict bed rest… Pain control was managed with medication of choice by surgeon and anesthesiologist.

Interventions

Carbohydrate drink loadDIETARY_SUPPLEMENT

Administration of 5% Dextrose orally as a carbohydrate drink load two hours before surgery and as an oral sips eight hours after the surgery.

Also known as: 5% Dextrose orally
ERAS arm

The ERAS intervention consisted of exposing patients to ERAS protocol of care as described by the ERAS Society® for the entire perioperative period. However, some of these ERAS protocols were modified to our local resources and requirements.

Also known as: Fast Track Surgery, Multimodal Rehabilitation
ERAS arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • We enrolled adult patients, 18 years of age and above, scheduled for non-emergency laparotomy.

You may not qualify if:

  • Patients with age less than 18 years
  • Pregnant patients
  • Emergency Laparotomy
  • American Society of Anesthesiologists (ASA) physical status score greater than 3
  • Surgeries other than elective gastrointestinal laparotomy
  • Diabetes patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mbarara Regional Referral Hospital

Mbarara, 00256, Uganda

Location

MeSH Terms

Interventions

Enhanced Recovery After Surgery

Intervention Hierarchy (Ancestors)

Perioperative CareSurgical Procedures, Operative

Study Officials

  • Serge M Tshijuke, MD, MMed

    Kabale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants were randomly allocated into two arms: intervention arm (ERAS) and control arm
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2018

First Posted

September 11, 2018

Study Start

June 1, 2017

Primary Completion

July 30, 2017

Study Completion

August 15, 2017

Last Updated

September 11, 2018

Record last verified: 2018-09

Locations